These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 35085554)
1. SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells. Kawase N; Sugihara A; Kajiwara K; Hiroshima M; Akamatsu K; Nada S; Matsumoto K; Ueda M; Okada M J Biol Chem; 2022 Mar; 298(3):101630. PubMed ID: 35085554 [TBL] [Abstract][Full Text] [Related]
2. CDCP1 promotes compensatory renal growth by integrating Src and Met signaling. Kajiwara K; Yamano S; Aoki K; Okuzaki D; Matsumoto K; Okada M Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574034 [TBL] [Abstract][Full Text] [Related]
3. HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion. Li W; Xiong X; Abdalla A; Alejo S; Zhu L; Lu F; Sun H J Biol Chem; 2018 Oct; 293(40):15397-15418. PubMed ID: 30108175 [TBL] [Abstract][Full Text] [Related]
4. Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling. Parr C; Ali AY J Transl Med; 2018 Oct; 16(1):281. PubMed ID: 30314527 [TBL] [Abstract][Full Text] [Related]
5. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells. Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621 [TBL] [Abstract][Full Text] [Related]
6. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells. Castro NE; Lange CA Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930 [TBL] [Abstract][Full Text] [Related]
7. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells. Xu H; Washington S; Verderame MF; Manni A Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746 [TBL] [Abstract][Full Text] [Related]
8. Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells. Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR Cell Biochem Funct; 2014 Aug; 32(6):485-95. PubMed ID: 24964901 [TBL] [Abstract][Full Text] [Related]
9. HGF-induced PKCζ activation increases functional CXCR4 expression in human breast cancer cells. Huang S; Ouyang N; Lin L; Chen L; Wu W; Su F; Yao Y; Yao H PLoS One; 2012; 7(1):e29124. PubMed ID: 22242160 [TBL] [Abstract][Full Text] [Related]
10. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Parr C; Jiang WG Int J Oncol; 2001 Oct; 19(4):857-63. PubMed ID: 11562767 [TBL] [Abstract][Full Text] [Related]
11. Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells. Kim EJ; Eom SJ; Hong JE; Lee JY; Choi MS; Park JH Mol Cell Biochem; 2012 Jan; 359(1-2):431-40. PubMed ID: 21892609 [TBL] [Abstract][Full Text] [Related]
13. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631 [TBL] [Abstract][Full Text] [Related]
14. Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells. Usatyuk PV; Fu P; Mohan V; Epshtein Y; Jacobson JR; Gomez-Cambronero J; Wary KK; Bindokas V; Dudek SM; Salgia R; Garcia JG; Natarajan V J Biol Chem; 2014 May; 289(19):13476-91. PubMed ID: 24634221 [TBL] [Abstract][Full Text] [Related]
15. LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells. Harrison SM; Knifley T; Chen M; O'Connor KL BMC Cancer; 2013 Oct; 13():501. PubMed ID: 24160245 [TBL] [Abstract][Full Text] [Related]
16. KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer. Park JJ; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M BMC Cancer; 2012 Mar; 12():81. PubMed ID: 22390300 [TBL] [Abstract][Full Text] [Related]
17. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889 [TBL] [Abstract][Full Text] [Related]
18. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases. Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678 [TBL] [Abstract][Full Text] [Related]
19. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells. Rahimi N; Hung W; Tremblay E; Saulnier R; Elliott B J Biol Chem; 1998 Dec; 273(50):33714-21. PubMed ID: 9837958 [TBL] [Abstract][Full Text] [Related]
20. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines. Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]